Literature DB >> 27301872

Buccal Dosage Forms: General Considerations for Pediatric Patients.

Soledad Montero-Padilla1, Sitaram Velaga2, Javier O Morales3,4.   

Abstract

The development of an appropriate dosage form for pediatric patients needs to take into account several aspects, since adult drug biodistribution differs from that of pediatrics. In recent years, buccal administration has become an attractive route, having different dosage forms under development including tablets, lozenges, films, and solutions among others. Furthermore, the buccal epithelium can allow quick access to systemic circulation, which could be used for a rapid onset of action. For pediatric patients, dosage forms to be placed in the oral cavity have higher requirements for palatability to increase acceptance and therapy compliance. Therefore, an understanding of the excipients required and their functions and properties needs to be particularly addressed. This review is focused on the differences and requirements relevant to buccal administration for pediatric patients (compared to adults) and how novel dosage forms can be less invasive and more acceptable alternatives.

Entities:  

Keywords:  buccal delivery; mucoadhesion; pediatric dosage forms; pediatric films; pediatric tablets; transmucosal

Mesh:

Substances:

Year:  2016        PMID: 27301872     DOI: 10.1208/s12249-016-0567-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  6 in total

Review 1.  Formulation Challenges and Strategies to Develop Pediatric Dosage Forms.

Authors:  Wedad A Malkawi; Enas AlRafayah; Mohammad AlHazabreh; Salam AbuLaila; Abeer M Al-Ghananeem
Journal:  Children (Basel)       Date:  2022-04-01

Review 2.  A mini-review on drug delivery through wafer technology: Formulation and manufacturing of buccal and oral lyophilizates.

Authors:  Juliana Souza Ribeiro Costa; Karen de Oliveira Cruvinel; Laura Oliveira-Nascimento
Journal:  J Adv Res       Date:  2019-05-03       Impact factor: 10.479

3.  Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System.

Authors:  Jose-Manuel delMoral-Sanchez; Isabel Gonzalez-Alvarez; Marta Gonzalez-Alvarez; Andres Navarro; Marival Bermejo
Journal:  Pharmaceutics       Date:  2019-10-31       Impact factor: 6.321

4.  Milk Oral Lyophilizates with Loratadine: Screening for New Excipients for Pediatric Use.

Authors:  Sonia Iurian; Cătălina Bogdan; Ștefana Suciu; Dana-Maria Muntean; Lucia Rus; Mihaela Berindeie; Szidonia Bodi; Rita Ambrus; Ioan Tomuță
Journal:  Pharmaceutics       Date:  2022-06-24       Impact factor: 6.525

5.  Development of a Mucoadhesive Vehicle Based on Lyophilized Liposomes for Drug Delivery through the Sublingual Mucosa.

Authors:  María José De Jesús Valle; Aranzazu Zarzuelo Castañeda; Cristina Maderuelo; Alejandro Cencerrado Treviño; Jorge Loureiro; Paula Coutinho; Amparo Sánchez Navarro
Journal:  Pharmaceutics       Date:  2022-07-19       Impact factor: 6.525

6.  Development of Mucoadhesive Buccal Film for Rizatriptan: In Vitro and In Vivo Evaluation.

Authors:  Anroop B Nair; Jigar Shah; Shery Jacob; Bandar E Al-Dhubiab; Vimal Patel; Nagaraja Sreeharsha; Pottathil Shinu
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.